Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05318131 · ClinicalTrials.gov registry record · NA

Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer

A NA study of Prostate Cancer, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05318131: Completed NA study of Prostate Cancer, sponsored by NYU Langone Health.

NCT05318131 is a NA study of Prostate Cancer that has completed, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05318131, a NA study of Prostate Cancer, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The primary objectives of this study are to examine sleep, exercise, and nutrition in prostate cancer.

Primary Outcome

The study team will use ActiGraph software to calculate device-based measures of sleep efficiency. Sleep efficiency is the ratio of total sleep time (total time spent asleep) to time in bed and is reported as a percentage (total sleep time / time in bed x 100).

Conditions Studied

Interventions

  • OTHER Sleep and Lifestyle Advice Website
  • OTHER Surveys and Sleep Monitors

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-08-30
Est. Completion 2023-10-12
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT05318131 record still lists

NCT05318131 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Sleep and Lifestyle Advice Website is the first listed.

NCT05318131 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05318131 about?

NCT05318131 is a clinical study titled "Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer". The primary objectives of this study are to examine sleep, exercise, and nutrition in prostate cancer.

What is the current status of trial NCT05318131?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-08-30. Estimated completion is 2023-10-12.

What conditions does trial NCT05318131 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05318131?

The interventions under investigation include: Sleep and Lifestyle Advice Website (OTHER), Surveys and Sleep Monitors (OTHER).

Who is sponsoring clinical trial NCT05318131?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05318131 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05318131's enrollment target sits among peer trials

50 469th of 735 higher than 247 of 735 other Prostate Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05318131, the US trial registry maintained by the National Library of Medicine. NCT05318131 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.